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ABSTRACT 
Objective: Latent autoimmune diabetes in adults (LADA) shares clinical features with both type 
1 and type 2 diabetes; however there is ongoing debate regarding the precise definition of 
LADA. Understanding its genetic basis is one potential strategy to gain insight in to appropriate 
classification of this diabetes subtype. 
Research Design and Methods: We performed the first genome-wide association study of 
LADA in cases of European ancestry versus population controls (n = 2,634 vs. 5,947), cases with 
type 1 diabetes (n = 2,454 vs. 968) and type 2 diabetes (n = 2,779 vs. 10, 396). 
Results: The leading genetic signals were principally shared with type 1 diabetes, although we 
observed positive genetic correlations genome-wide with both type 1 and type 2 diabetes. 
Additionally, we observed a novel independent signal at the known type 1 diabetes locus 
harboring PFKFB3, encoding a regulator of glycolysis and insulin signaling in type 2 diabetes 
and inflammation and autophagy in autoimmune disease, as well as an attenuation of key type 1-
associated HLA haplotype frequencies in LADA, suggesting that these are factors that 
distinguish childhood-onset type 1 diabetes from adult autoimmune diabetes. 
Conclusion: Our results support the need for further investigations of the genetic factors that 
distinguish forms of autoimmune diabetes, as well as more precise classification strategies. 
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The relationship between LADA and both type 1 diabetes and type 2 diabetes is not fully 
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scores combining known type 1 and type 2 diabetes loci and assessed their impact in LADA, and 
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appraisal of adult autoimmune diabetes has been performed. Therefore, in this study, we 
performed the first GWAS of LADA against population controls and further contrasted LADA 
against type 1 diabetes and type 2 diabetes to better understand its genomic signature in 
comparison to these two better characterized forms of diabetes.
METHODS 
Study subjects  
Cases diagnosed with LADA were included from cohorts of European ancestry 
(Supplementary Table 1), including ‘ActionLada-Plus,’ All New Diabetics In Scania (ANDIS), 
the Botnia Study, Copenhagen LADA (including samples from Danish Centre for strategic 
Research in Type 2 Diabetes (DD2), Vejle Biobank, Odense University Hospital (OUH), 
Copenhagen Insulin and Metformin Therapy trial (CIMT), Inter99, and Steno Diabetes Center 
(SDC)), the Diabetes Registry Vasa (DIREVA), GoDARTS, Nord-Trøndelag Health Study 
(HUNT), and Scania Diabetes Registry (SDR). Controls were population-based (including 
samples from the Bone Mineral Density in Childhood Study (BMDCS), Copenhagen controls 
(with samples from the 1936 Birth Cohort and ADDITION-PRO), GoDARTS, HUNT, and the 
Malmö Diet and Cancer study, DIREVA, and SDR). 
Inclusion and exclusion criteria for LADA, type 1 diabetes, type 2 diabetes, and population 
controls varied by cohort (see Supplementary Table 1 and Supplementary Note for details). In 
general, LADA was defined by an age at diagnosis older than 20, 30 or 35 years, with some 
cohorts restricting the upper age limit to 70 years; the presence of diabetes-associated 
autoimmune autoantibodies, in particular GADA-positivity; and the lack of insulin requirement 
for 6 months or 1 year after diagnosis. In some cases, C-peptide level was also used as a filter.  
 
Genotyping and imputation 
Each respective cohort performed genome-wide genotyping on the Illumina CoreExome 
chip, the Illumina OmniExpressExome BeadChip, or the Affymetrix 6 array. Cases and controls 
from each study center were matched on the same genotyping chip to reduce batch effects. 
Standard post-genotyping quality control was performed, including sample exclusions for 
ambiguous gender, call rate < 95%, and any duplicate or related individuals (pi_hat ≥ 0.2), and 
SNP exclusions for monomorphic SNPs, SNPs with MAF < 0.05, and SNPs with missingness 
rate > 0.05. The Haplotype Reference Consortium (HRC) imputation service (Michigan 
imputation server, https://imputationserver.sph.umich.edu/index.html) was utilized to perform 
imputation for autosomal SNPs.  
 
Genome-wide association and meta-analysis: LADA vs. controls, LADA vs. type 1 diabetes, and 
LADA vs. type 2 diabetes 
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"http://genome.sph.umich.edu/wiki/EPACTS" \t "pmc_ext" }) was used by each respective 
cohort to perform case-control GWAS of LADA (n = 2,634) vs. population controls (n = 5,947),  
LADA (n = 2,454) vs. cases with type 1 diabetes (n = 968), and LADA (n = 2,779) vs. cases with 
type 2 diabetes (n = 10, 396), including sex and principal components as covariates (see 
Supplementary Table 1 for cohort-specific covariates).  
After GWAS, filtering was performed centrally to include only SNPs with a MAF > 0.05, INFO 
quality score > 0.4, and a Hardy-Weinberg equilibrium P > 1x10-7. Meta-analysis was then 
performed for LADA vs. population controls, LADA vs. type 1 diabetes, and LADA vs. type 2 
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(Supplementary Table 2; Supplementary Fig. 1-2). 
Signals in the secondary tier (P = 1 x 10-6 – 5 x 10-8) for the LADA vs. population controls 
analysis were followed up in the GODARTS and HUNT cohorts (LADA, n = 345; controls, n = 
1,664) and meta-analyzed with the discovery set (total LADA, n = 2,979; controls, n = 7,611) to 
assess whether any novel signals would reach genome-wide significance.  
Enrichment of directional consistency among T1D/T2D loci in LADA 
To estimate whether the concordance in direction of effects for T1D and T2D loci in LADA is 
significantly different from chance, a binomial test was used assuming a null hypothesis of 50% 
agreement.  
 
Conditional analysis 
Approximate conditional analysis for known type 1 diabetes-associated loci was carried out 
for the LADA vs controls summary statistics results for the 10p15.1 locus using Genome-wide 
Complex Trait Analysis (GCTA).{ ADDIN ZOTERO_ITEM CSL_CITATION 
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summary statistics were conditioned on the following type 1 diabetes-associated SNPs: 
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tertiles with the highest GAD titers (n = 1012) vs. population controls (n = 4314); and (3) the 
bottom tertile with the lowest GAD titers (n = 562) vs. population controls (n = 4314).  
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type 1 diabetes cases from the WTCCC (n = 1,990). HLA alleles with 4-digit resolution were 
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across LADA, type 1 diabetes, and BMDCS were removed from the analysis given that rare 
haplotypes can result in unstable variance estimates and unreliable test statistics.  
 
 
RESULTS 
Genome-wide association of LADA versus population controls 
We first conducted GWAS in patients with LADA (n = 2,634) versus population-based 
controls (n = 5,947) of European ancestry in a discovery meta-analysis setting (Supplementary 
Table 1; power calculations can be found in Supplementary Table 3). Four signals achieved 
genome-wide significance (P < 5x10-8), all at established type 1 diabetes risk loci (HLA, 
PTPN22, INS, and SH2B3; Table 1, Supplementary Figures 1 and 2). Pathway analysis with 
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immune role in the pathogenesis of LADA (Supplementary Tables 4-5), with gene set 
enrichment analysis implicating ‘abnormal cytotoxic T cell physiology’ (nominal P = 6.39 x 10-
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‘natural killer cells’ and ‘T lymphocytes’ (nominal P = 0.0079 and 0.0082, respectively). This is 
consistent with previous reports of these cell types playing a role in the pathogenesis of type 1 
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Replication supports a novel locus at PFKFB3 
Using cases with LADA and population samples from an additional two study centers, we 
attempted validation of 13 signals with suggestive association (P < 5x10-5) (Supplementary 
Table 6). We observed a novel signal at 10p15.1 between the two established type 1 diabetes 
loci at IL2RA and PRKCQ, which achieved genome-wide significance (rs1983890-C, OR (95% 
CI) = 1.16 (1.14-1.32), P = 3.02 x 10-8) (Fig. 1A-B). Given that the LADA signal is situated in 
close proximity to known type 1 diabetes risk loci and was in moderate to low LD with 
established type 1 diabetes-associated alleles (Supplementary Table 7), we conditioned on the 
type 1 diabetes SNPs and observed that rs1983890 remained strongly associated with LADA 
(OR (95% CI) = 1.15 (1.13-1.19), P = 4.35 x 10-8) (Fig. 1C). This signal reached suggestive 
association in a study of type 1 diabetes (P = 1.3 x 10-7) { ADDIN ZOTERO_ITEM 
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2-Kinase/Fructose-2,6-Biphosphatase 3’ (PFKFB3), the nearest gene to the LADA signal, as the 
most likely functional candidate (Supplementary Table 8). 
 
Candidate loci for type 1 diabetes and type 2 diabetes 
Some of the loci that were suggestively associated with LADA in this study overlap 
previously documented type 1 diabetes associations, including rs11755527 (BACH2) and 
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rs11888640 (THADA). Taking a candidate gene approach, we extracted 66 established type 1 
diabetes-associated loci from the LADA vs. population controls meta-analysis and found that 17 
of these yielded association with LADA after multiple-test correction (P < 7.6 x 10-4, 
Supplementary Table 9). Taking a similar approach with 65 established type 2 diabetes loci, 
none surpassed the significance threshold; however, at the nominal significance level (P < 0.05), 
eleven type 1 diabetes and eleven type 2 diabetes variants were associated with LADA, all 
having the same direction of effect as seen for type 1 diabetes and type 2 diabetes, respectively, 
except for the type 2 diabetes locus CILP2 (rs10401969-T, OR = 0.820 (0.726-0.927), P = 
0.0016; Supplementary Table 10). On the whole, both type 1 diabetes and type 2 diabetes loci 
had lower P-values in LADA than expected by chance (Supplementary Figure 3).  
Approximately 90.6% of T1D loci (Supplementary Table 9) had directional consistency in 
LADA (P-value = 4.51 x 10-12) and 72.3% of T2D loci (Supplementary Table 10) had 
directional consistency in LADA (P-value = 2.10 x 10-4). Combining T1D and T2D loci, 81.4% 
had directional consistency in LADA (P-value = 1.40 x 10-13).  Therefore, we observed a 
significant enrichment of established T1D and T2D loci having the same directional effect in 
LADA.  
 
 
GWAS of LADA versus type 2 diabetes and type 1 diabetes 
Next, we compared LADA with type 2 diabetes at the genome-wide level. Similar to the 
results of LADA vs. population controls, LADA (n = 2,454) vs. type 2 diabetes (n = 10,396) 
yielded genome-wide significance for the same four type 1 diabetes risk loci (Table 1). We then 
performed a GWAS of LADA (n = 2,454) vs. type 1 diabetes (n = 968) to assess whether any 
differences could be detected. Only the HLA region was significantly different between type 1 
diabetes and LADA, representing a relative depletion of the lead signal in LADA when 
compared to type 1 diabetes (rs9273368-A, OR (95% CI) = 0.335 (0.256-0.385), P = 8.46 x 10-
40; Table 1). Leveraging the entire genome-wide summary statistics, genetic correlation analyses 
showed that LADA was positively correlated with both type 1 diabetes (with the inclusion of the 
HLA; rg (SE) = 0.385 (0.136), P = 0.0047) and type 2 diabetes (without the HLA; rg (SE) = 
0.281 (0.106), P = 0.008). 
 
Stratified GWAS of LADA by GAD autoantibody tertile 
Stratifying LADA cases into tertiles resulted in the detection of the same four loci, although the 
magnitude of the associations differed between the top tertile vs. population controls, the top 2 
tertiles vs. population controls, and the bottom tertile vs. population controls (Supplementary 
Table 11). As expected, the ORs for the leading loci were strongest in the LADA cases with the 
highest GAD autoantibody titers. For example, rs9273368 (HLA-DQB1) showed the strongest 
association with LADA in the analysis including the top tertile of GAD autoantibody titer (OR 
(95% CI) = 3.30 (2.81-3.88), P = 1.89x10-47) and the lowest association in the bottom GAD 
autoantibody tertile (OR (95% CI) = 2.42 (2.06-2.85), P = 2.13x10-26). Furthermore, only the 
HLA-DQB1 locus was significantly associated in the LADA cases with the lowest GAD titers, 
while the PTPN22, INS, and SH2B3 loci were only evident among cases with higher GAD titers. 
Furthermore, rs7903146 at TCF7L2 had a slightly higher OR in the group with the lowest GAD 
titer than that with the lowest GAD titer (1.09 vs. 1.05, respectively). 
 
HLA haplotype analysis 
To further investigate differences in the HLA region between LADA and type 1 diabetes, we 
imputed this region using SNP2HLA{ ADDIN ZOTERO_ITEM CSL_CITATION 
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type 1 diabetes-associated HLA haplotypes (Supplementary Table 12). After removing 
haplotypes with less than 1% frequency, fifteen known type 1 diabetes-associated HLA 
haplotypes were tested for association in LADA compared to type 1 diabetes. Eleven type 1 
diabetes haplotypes were significantly different in frequency between LADA and type 1 diabetes 
cases after correction for multiple testing (P < 0.003), with all but four being protective against 
type 1 diabetes.{ ADDIN ZOTERO_ITEM CSL_CITATION 
{"citationID":"a1o44kjhe2d","properties":{"formattedCitation":"(33)","plainCitation":"(33)","no
teIndex":0},"citationItems":[{"id":"GKyl1X7D/pbo89MDT","uris":["http://zotero.org/users/loca
l/99dTDuE7/items/ZGJDRTHI"],"uri":["http://zotero.org/users/local/99dTDuE7/items/ZGJDRT
HI"],"itemData":{"id":249,"type":"article-journal","title":"Genetics of Type 1 
Diabetes","container-title":"Cold Spring Harbor Perspectives in 
Medicine","volume":"2","issue":"1","source":"proxy.library.upenn.edu:2063","abstract":"Geneti
c susceptibility to type 1 diabetes (T1D) has been a subject of intensive study for nearly four 
decades. This article will present the history of these studies, beginning with observations of the 
Human Leukocyte Antigen (HLA) association in the 
...","URL":"https://proxy.library.upenn.edu:2063/pmc/articles/PMC3253030/","DOI":"10.1101/c
shperspect.a007732","note":"PMID: 22315720","author":[{"family":"Noble","given":"Janelle 
A."},{"family":"Erlich","given":"Henry A."}],"issued":{"date-
parts":[["2012",1]]},"accessed":{"date-
parts":[["2017",2,21]]}}}],"schema":"https://github.com/citation-style-
language/schema/raw/master/csl-citation.json"} } The four type 1 diabetes susceptibility 
haplotypes, HLA-DRB1*0301-DQA1*0501-DQB1*0201, HLA-DRB1*0401-DQA1*0301-
DQB1*0302, HLA-DRB1*0404-DQA1*0301-DQB1*0302, and HLA-DRB1*0405-
DQA1*0301-DQB1*0302{ ADDIN ZOTERO_ITEM CSL_CITATION 
{"citationID":"amk762ljj9","properties":{"formattedCitation":"(33)","plainCitation":"(33)","note
Index":0},"citationItems":[{"id":"GKyl1X7D/pbo89MDT","uris":["http://zotero.org/users/local/
99dTDuE7/items/ZGJDRTHI"],"uri":["http://zotero.org/users/local/99dTDuE7/items/ZGJDRTH
I"],"itemData":{"id":249,"type":"article-journal","title":"Genetics of Type 1 
Diabetes","container-title":"Cold Spring Harbor Perspectives in 
Medicine","volume":"2","issue":"1","source":"proxy.library.upenn.edu:2063","abstract":"Geneti
c susceptibility to type 1 diabetes (T1D) has been a subject of intensive study for nearly four 
decades. This article will present the history of these studies, beginning with observations of the 
Human Leukocyte Antigen (HLA) association in the 
...","URL":"https://proxy.library.upenn.edu:2063/pmc/articles/PMC3253030/","DOI":"10.1101/c
shperspect.a007732","note":"PMID: 22315720","author":[{"family":"Noble","given":"Janelle 
A."},{"family":"Erlich","given":"Henry A."}],"issued":{"date-
parts":[["2012",1]]},"accessed":{"date-
parts":[["2017",2,21]]}}}],"schema":"https://github.com/citation-style-
language/schema/raw/master/csl-citation.json"} }, had significantly lower frequencies in LADA 
than in type 1 diabetes. 
 
DISCUSSION 
Taken collectively, GWAS and HLA haplotype analyses based on established associations, 
along with gene set enrichment analyses, support the hypothesis that the strongest genetic risk 
loci for LADA are shared with type 1 diabetes, but that established type 2 diabetes alleles also 
play a weaker role, as evidenced by the enrichment of established type 2 diabetes loci in LADA 
and the positive genetic correlation between LADA and type 2 diabetes. The strong type 1 
diabetes-like signature seen here in adult autoimmune diabetes could be explained by the 
differing genetic architectures between the two main types of diabetes{ ADDIN 
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frequency risk variants with high odds ratios while type 2 diabetes has many common risk 
variants with smaller effect sizes. Given these architectural differences, any trait with a type 1 
diabetes-like genetic component will detect type 1 signals first, and would only subsequently 
detect the type 2 signals with increased statistical power (Supplementary Table 3).  
Furthermore, this has important implications for genetic studies of type 2 diabetes, in which 
misdiagnosed autoimmune diabetes cases are not routinely screened out. With increasing sample 
sizes and the ability to detect additional loci, type 2 diabetes GWAS that are ‘contaminated’ with 
adult autoimmune cases will inevitably begin to detect type 1 diabetes-associated genetic loci, 
potentially mis-assigning these loci to type 2 diabetes etiology. 
  In comparing LADA to the general population, we identified a novel independent genome-
wide significant signal at the PFKFB3 locus that persisted after conditioning on the two nearby 
type 1 diabetes-associated signals on chromosome 10p15. Cumulative evidence for the 10p15 
locus suggests it is a complex region associated with autoimmune diabetes, given that it already 
harbors two established risk alleles for type 1 diabetes{ ADDIN ZOTERO_ITEM 
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studies strongly support PFKFB3 as a plausible biological candidate in diabetes, given its gene 
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autoimmune diseases; in T cells from rheumatoid arthritis patients, PFKFB3 is lost leading to 
decreased T cell glucose consumption and impaired autophagy, which in turn lead to an inability 
to mount a normal immune response and an increase in T cell apoptosis.{ ADDIN 
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investigate the role of PFKFB3 in LADA, and to determine whether this signal is truly a 
distinguishing feature between adult and childhood-onset autoimmune diabetes.  
Although the lead genome-wide significant loci are shared with those for type 1 diabetes risk, 
they clearly have a diminished impact in LADA. To further investigate the differences between 
LADA and type 1 diabetes at the HLA region, we performed a comparative haplotype analysis 
that showed a decreased frequency of type 1 diabetes-associated risk haplotypes in LADA. This 
could be partly explained by the established age gradient in HLA frequencies seen in type 1 
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Furthermore, while previous studies showed an association for the leading type 2 diabetes risk 
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this finding (Supplementary Table 10)  (LADA vs. population controls, rs7903146-T: OR (95% 
CI) = 1.107 (1.024-1.20), P = 0.011), which may be due to the limited power of our study to 
detect type 2 diabetes signals (Supplementary Table 2). To understand the evidence supporting 
the previous association, we examined the allele frequencies of the lead variant in each 
contributing cohort. This revealed that the difference in risk allele frequency between cases and 
controls was cohort-specific, with only one case-control set (ActionLADA cases vs BMDCS 
controls) not supporting this association, principally due to the higher frequency of the risk allele 
in the control set (Supplementary Table 13). One possibility is that inclusion or exclusion of 
type 2 diabetes patients from control cohorts would affect the frequency of the risk allele; 
however, sensitivity analysis with control sets that either excluded or included diabetic patients 
in Swedish and Danish samples showed the persistence of an association (Supplementary Table 
13), although not at the genome-wide significance level. Interestingly, a recent study found that 
the type 2 diabetes risk allele at the key TCF7L2 locus was associated with type 1 diabetes cases 
who were older than 12 years at onset and were positive for only a single autoimmune antibody.{ 
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associated with higher C-peptide area under the curve (AUC) (P = 0.008) and lower mean 
glucose AUC (P = 0.0127). The results were similar for the rs7901695 SNP.\nCONCLUSIONS 
In this cohort of individuals with new-onset type 1 diabetes, type 2 diabetes–linked TCF7L2 
variants were associated with single autoantibody (among those ≥12 years old), higher C-peptide 
AUC, and lower glucose AUC levels during an OGTT. Thus, carriers of the TCF7L2 variant had 
a milder immunological and metabolic phenotype at type 1 diabetes diagnosis, which could be 
partly driven by type 2 diabetes–like pathogenic mechanisms.","DOI":"10.2337/dc17-
0961","ISSN":"0149-5992, 1935-5548","note":"PMID: 
29025879","language":"en","author":[{"family":"Redondo","given":"Maria 
J."},{"family":"Geyer","given":"Susan"},{"family":"Steck","given":"Andrea 
K."},{"family":"Sosenko","given":"Jay"},{"family":"Anderson","given":"Mark"},{"family":"An
tinozzi","given":"Peter"},{"family":"Michels","given":"Aaron"},{"family":"Wentworth","given"
:"John"},{"family":"Xu","given":"Ping"},{"family":"Pugliese","given":"Alberto"}],"issued":{"d
ate-parts":[["2017",9,12]]}}}],"schema":"https://github.com/citation-style-
language/schema/raw/master/csl-citation.json"} } That study provides further evidence for a role 
for type 2 diabetes genetic risk in later-onset autoimmune diabetes and resonates with the 
genome-wide observations we report here in adults. 
The precise diagnostic criteria used to distinguish LADA from adult-onset type 1 and type 2 
diabetes remain under debate. These differences in opinion have hindered the collection of well-
phenotyped, clearly defined LADA cohorts for genetic studies, and are reflected in the cohorts 
we included in this study, e.g. in terms of heterogeneous age inclusion thresholds and differences 
in autoantibody testing. In this study, we strove to be inclusive to maximize our sample size and 
statistical power, but we acknowledge that stringent, deeply phenotyped cohorts are needed to 
truly address where adult autoimmune diabetes is placed on the diabetes spectrum. Another 
debate surrounds the idea that LADA cohorts may simply be collections of poorly phenotyped 
cases with adult-onset type 1 and type 2 diabetes, and refute the idea that LADA is a unique 
disease entity. However, GAD assays have a specificity of 95–98%, so by implication, some 
cases with type 2 diabetes with low-level GAD can be incorrectly classified as LADA cases; 
these would, however, represent only a very small fraction of cases since the predictive 
specificity of GAD would have been increased by our cohort enrichment as with any biomarker 
assay. Conversely, the small percentage of cases with LADA who do not have GAD positivity 
but have other islet autoantibodies and are misclassified as having type 2 diabetes, could affect 
the estimate of genetic correlation between LADA and type 2 diabetes to a small degree. Future 
studies should focus on defining the heterogeneity and misdiagnosis rates among patients with 
LADA. 
Despite these limitations, using the definition of LADA presented here, we identified factors 
which potentially distinguish this form of adult autoimmune diabetes from childhood-onset type 
1 diabetes as well as type 2 diabetes: (1) a novel signal at the PFKFB3 locus, and (2) attenuation 
of type 1-associated HLA risk haplotypes. Overall, we find the presence of both a type 1 
diabetes-like autoimmune genetic component and a type 2 diabetes-like 
metabolic/anthropometric genetic component consistent with the phenotypic features of both 
main diabetes types, suggesting that LADA as defined here is a hybrid of these two major 
diseases. Our findings promote the hypothesis that the polygenic component that contributes 
susceptibility to type 2 diabetes can act as a modifier to type 1 diabetes risk, possibly as a 
‘second hit’ in individuals who have moderate underlying autoimmune susceptibility that is 
insufficient to trigger childhood type 1 diabetes but greater than that of the general population 
and sufficient to lead to clinical diabetes in adulthood. Taken together, future studies should 
examine the role of body mass index, which is lower in type 1 diabetes and higher among 
patients with type 2 diabetes, in adult autoimmune diabetes, as well as further defining the role of 
factors that potentially distinguish adult autoimmune diabetes from type 1 and type 2 diabetes. 
CONCLUSION 
In this first GWAS of LADA, we show that the leading genome-wide significant signals 
point towards LADA as being a late-onset form of type 1 diabetes, albeit with a genetically 
attenuated potency of key type 1 diabetes-associated HLA haplotypes, but also with a type 2 
diabetes-like genetic component. Further in-depth studies are necessary to address how LADA 
and insulin dependence develops and to study the impact of heterogeneity among cases with 
LADA, as well as a need for functional studies to investigate how the glycolytic regulator 
PFKFB3 is situated at the intersection of autoimmune and metabolic diabetes. Furthermore, our 
LADA dataset should act as a resource to help mitigate the unaccounted presence of autoimmune 
diabetes in patients masquerading as type 2 diabetes, with implications both for GWAS studies 
and for clinical management. 
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Table 1. Genome-wide significant signals associated with LADA. We performed three 
genome-wide association approaches, first for LADA versus population controls (top panel), 
then for LADA versus type 1 diabetes (type 1 diabetes, middle panel) and LADA versus type 2 
diabetes (type 2 diabetes, lower panel). Odds ratios (ORs) are given for the LADA risk allele 
except for rs92773368 in LADA vs. type 1 diabetes, to illustrate that the type 1 diabetes risk 
allele was depleted in LADA. 
 
 
 
 
 
 
FIGURE LEGENDS 
Figure 1. LocusZoom plots for the PFKFB3 locus. (A) In LADA vs. population controls with the 
addition of replication samples, rs1983890 reached borderline genome-wide significance. (B) 
This signal lies in between two type 1 diabetes-associated loci at 10p15.1(21). (C) When we 
conditioned on the two known type 1 diabetes loci, the signal in LADA remained. LocusZoom 
plots were constructed to show the association data of SNPs 400kb upstream and downstream of 
the lead LADA-associated signal at rs1983890.   
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Figure 1. QQ plots for (A) LADA vs. population controls, (B) LADA vs. T1D, and (C) LADA vs. T2D 
 
 
 
 
 
 
 
Figure 2. Manhattan plots for (A) LADA vs. population controls, (B) LADA vs. T1D, and (C) LADA vs. T2D
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. QQ plots showing established T1D (red) and T2D (blue) loci in LADA vs. population controls. A) All 
loci; B) zoomed in at 1 > P > < 10-4 (excluding top T1D signals).. 
A. 
B.  
  
 
 
Supplementary Note: Cohort Information 
 
Cohort name: Action Lada 
Cohort type: LADA cases 
Inclusion/exclusion criteria: Patients were designated with diabetes according to standard criteria, and LADA was 
defined as follows: patients 1) aged 30–70 years, 2) with diabetes associated autoantibodies, and 3) who did not 
require insulin treatment for at least 6 months post diagnosis. Type 1 autoimmune diabetic patients were defined as 
case subjects with diabetes and with diabetes-associated autoantibodies where insulin was started at diagnosis or 
within 1 month of diagnosis. Inclusion criteria for all patients were that patients have diabetes (with at least two 
recorded fasting blood glucose measurements >7 mmol/L), that time from diagnosis was 5 years for all patients, and 
that patients were aged 30–70 years at the time of recruitment. Exclusion criteria were insufficient dataset, current 
pregnancy, renal disease with raised creatinine or proteinuria, or acute illness at the time of testing. 
Number of study subjects: 1098 
Acknowledgements: We would like to acknowledge the Action Lada consortium. 
Funding: This study was partially funded by the 5th Framework Programme of the European Union. 
Cohort reference: REC Reference P/02/240 
Conflicts of interest: No potential conflicts of interest relevant to this work. 
Cohort name: Action Lada ‘Plus’ 
Cohort type: LADA cases 
Inclusion/exclusion criteria: Patients were designated with diabetes according to standard criteria, and LADA was 
defined as follows: patients 1) aged 30–70 years, 2) with diabetes associated autoantibodies, and 3) who did not 
require insulin treatment for at least 6 months post diagnosis. Type 1 autoimmune diabetic patients were defined as 
case subjects with diabetes and with diabetes-associated autoantibodies where insulin was started at diagnosis or 
within 1 month of diagnosis. Inclusion criteria for all patients were that patients have diabetes (with at least two 
recorded fasting blood glucose measurements >7 mmol/L), that time from diagnosis was 5 years for all patients, and 
that patients were aged 30–70 years at the time of recruitment. Exclusion criteria were insufficient dataset, current 
pregnancy, renal disease with raised creatinine or proteinuria, or acute illness at the time of testing. 
Number of study subjects: 441 
Acknowledgements:  
Funding:  
Cohort reference:  
Conflicts of interest:  
 
Cohort name: All New Diabetics In Scania (ANDIS) 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Inclusion/exclusion criteria: 
GAD  
ELISA: Negative:< 5 kE/L, Positive:=> 10 kE/L  
RIA: Negative:0-34 U/ml, Positive:> 50 U/ml 
LADA  
Age at onset ≥ 35 years 
GAD (ELISA) > 10 kE/L 
GAD (RIA) >50 U/ml 
 
Non-Scandinavian individuals excluded 
Number of study subjects: 440 
Acknowledgements: We thank all the patients and the health care providers across Scania and Ostrobothnia for 
their support and their willingness to participate. We would also like to thank Johan Hultman, Jasmina Kravic, 
Maria Fälemark, Christina Rosborn, Gabriella Gremsperger, Maria Sterner, Malin Neptin, Lisa Sundman, Paula 
Kokko, and Ulrika Blom-Nilsson for excellent technical and administrative support. Finally we would like to thank 
Rita Jedlert and Region Skåne (Scania County) as well as the ANDIS steering committee for their support. 
Funding: Supported by grants from the Swedish Research Council (including project grants Dnr.521-2010-3490 
and infrastructure grants Dnr. 2010-5983 and Dnr 2012-5538 to LG), Linnéus grant 349-2006-237, a strategic 
research grant (Exodiab Dnr 2009-1039), an ERC Advanced Research grant (GA 269045) and Academy of Finland 
(grants no. 263401 and 267882) to LG. 
Cohort reference: http://andis.ludc.med.lu.se/ 
Conflicts of interest: None 
Cohort name: Bone Mineral Density in Childhood Study (BMDCS) 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): population controls 
Cohort description: The Bone Mineral Density in Childhood Study is a multicenter, longitudinal study of bone 
accrual in healthy children.  
Inclusion/exclusion criteria: Only individuals of European ancestry were included. 
Number of study subjects: 1056 
Acknowledgements: We appreciate the dedication of the study participants and their families, and the support of 
Dr. Karen Winer, Scientific Director of the Bone Mineral Density in Childhood Study. 
Funding: The BMDCS was funded by the National Institutes of Health [grant number R01 HD58886 to B.Z. and 
S.G.]; the Eunice Kennedy Shriver National Institute of Child Health and Human Development [grant numbers N01-
HD-1-3228, -3329, -3330, -3331, -3332, -3333]; the Clinical and Translational Science Awards Program [grant 
number 8 UL1 TR000077]; American Diabetes Association Grant 1-17-PDF-077 [to D.C.]; and the Institute for 
Translational Medicine and Theraputics (ITMAT) Transdisciplinary Program in Translational Medicine and 
Therapeutics (to D.C., B.V., and S.G.). The project described was supported by the National Center for Research 
Resources [grant number UL1RR024134], and is now at the National Center for Advancing Translational Sciences 
[grant number UL1TR000003].  The content is solely the responsibility of the authors and does not necessarily 
represent the official views of the NIH. The funders had no role in the design and conduct of the study; collection, 
management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and 
decision to submit the manuscript for publication.  
Conflicts of interest: None 
Study cohort: Copenhagen Controls 
The Copenhagen Control sample is collected from two cohorts (The 1936 birth cohort and ADDITION-PRO), and 
comprises 1974 non-diabetic adults. The control subjects had a mean age of 64.42 (range, 34.44), and 49.9% were 
male. 
Cohort name: The 1936 birth cohort 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): Population controls 
Cohort description/inclusion/exclusion criteria: The cohort consists of all subjects born in 1936, who, on 2 April 
1976, were resident in one of four municipalities nearby Glostrup Hospital, Denmark (n=695). The cohort was 
collected to assess the age-specific prevalence of diabetes mellitus and impaired glucose tolerance in 60-year-old 
individuals in 1996/97. 
Number of study subjects: 624 non-diabetic individuals (502 NGTs, 122 IFG/IGTs) 
Acknowledgements: The authors are grateful to the staff at the Centre of Preventive Medicine, and to MD, general 
practitioner, Professor Hanne Hollnagel Dr Med. Sci., who initiated the study of the 1936 cohort. 
Funding: The collection of the cohort was financially supported by The Danish Heart Foundation and The Danish 
Medical Research Council. 
Cohort reference: Drivsholm T. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 
60-year-old Danes. Diabet Med 2001. 
Conflicts of interest: NA 
 
Cohort name: ADDITION-PRO 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): Controls 
Cohort description/inclusion/exclusion criteria: ADDITION-PRO is a longitudinal cohort study of 2082 adults 
(>45 years) collected to have IGT, IFG, or NGT either with high or low risk of developing type 2 diabetes (based on 
information about age, sex, gestational diabetes, family history of diabetes, hypertension, BMI, and level of physical 
activity).  
The samples were collected in 2009–2011from four Danish research centres (Steno Diabetes Center, Aarhus 
University Hospital, Holstebro Hospital, and Hospital of South West Jutland, Esbjerg). 
Number of study subjects: 1350 non-diabetic individuals (812 NGTs, 538 IFG/IGTs) 
Acknowledgements: The ADDITION-PRO study is managed by the ADDITION-DK steering committee (Torsten 
Lauritzen, Knut Borch-Johnsen, Annelli Sandbæk, Marit E. Jørgensen, and Daniel Witte). 
Funding: The ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the 
Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes 
(74550801), the Danish Council for Strategic Research, internal research and equipment funds from Steno Diabetes 
Center and supported by research grants from the Novo Nordisk Foundation.  
Cohort reference: Johansen et al. Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular 
experience of individuals at high risk for diabetes recruited from Danish primary care. BMC Public Health 2012. 
Conflicts of interest: NA 
Study cohort: Copenhagen LADA 
The Copenhagen LADA sample (n=539) is collected from six cohorts (DD2, Vejle Biobank, OUH, CIMT, Inter99, 
and SDC). The LADA patients had a mean age of 58.32 (range, 67.31), and 56.2% were male. 
The following inclusion criteria for LADA have been applied in all sub-cohorts: GADA positive, ≥20 years at the 
time of diagnosis, and treated without insulin for the first year after diagnosis or having fasting serum C-peptide 
≥300 pmol/L at the time of investigation. 
Cohort name: Danish Centre for strategic Research in Type 2 Diabetes (DD2) 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: DD2 is nationwide cohort, enrolling patients with newly 
diagnosed type 2 diabetes from general practitioners and hospital specialist outpatient clinics since 2010. GADA 
was measured in 5966 patients, with an AESKULISA assay. 
Number of study subjects: 158 LADA cases 
Acknowledgements: The DD2-project partners are listed on the website ww.DD2.nu. 
Funding: The DD2 study is supported by the Danish Agency for Science (grant no. 09-067009 and 09-075724), the 
Danish Health and Medicines Authority, the Danish Diabetes Association, and an unrestricted donation from Novo 
Nordisk A/S. 
Cohort reference: Thomsen et al. The Danish Centre for Strategic Research in Type 2 Diabetes (DD2): 
Organization of diabetes care in Denmark and supplementary data sources for data collection among DD2 study 
participants. Clin Epidemiol 2012. 
Conflicts of interest: NA 
 
Cohort name: Vejle Biobank 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: The Vejle Diabetes Biobank was established as a regional Bio 
bank and comprises individuals with diabetes and a gender- and age-matched control population. All participants 
were aged between 25 and 75 years (both ages included) and residing in the former County of Vejle area on 
December 31, 2006. Altogether, 3320 patients with type 2 diabetes or type 1 diabetes were recruited from the central 
database at Vejle Hospital Laboratory Center. GADA were measured in all 3320 patients, with an AESKULISA 
assay. 
Number of study subjects: 124 LADA cases 
Acknowledgements: The laboratory technologists Britta Kristensen, Lene Juul Hansen, Annette Kaaris, Jan 
Johannsen, Merete Willumsen, Birgitte Henriksen, Camilla Davidsen, and Sara Egsgaard are acknowledged for their 
continued engagement and dedicated work. 
Funding: The Vejle Biobank project was funded by the Danish Council for Independent Research/Medical 
Sciences, the Research Council of Vejle Hospital, the Department of Internal Medicine, Vejle Hospital, Vejle 
County, the Danish Research Fund, the Lions Club International Denmark, and anonymous donations. 
Cohort reference: Petersen et al. Vejle Diabetes Biobank – a resource for studies of the etiologies of diabetes and 
its comorbidities. Clin Epidemiol. 2016. 
Conflicts of interest: NA 
 
Cohort name: OUH 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: The OUH LADA cohort is collected from a database of patients 
with diabetes newly referred to Odense University Hospital (OUH), Denmark, between 1997 and 2011. GAD 
autoantibodies were measured in 5,671 patients with diabetes, applying an RSR RIA assay, 279 were GADA 
positive, above 30 years of age, and had fasting C-peptide above 300 pmol/l. Of these DNA was available for 66. 
Number of study subjects: 66 LADA cases 
Acknowledgements: Department of Endocrinology, Odense University Hospital, Denmark, is acknowledged for 
their collection of the OUH cohort. 
Funding: NA 
Cohort reference: NA 
Conflicts of interest: NA 
 
Cohort name: CIMT 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: The CIMT trial is a multicenter randomized placebo controlled 
superiority trail conducted from 2008 to 2012 at eight hospitals in the capital region of Denmark. Inclusion criteria 
included diagnosis of type 2 diabetes, >30 years at diagnosis, BMI >25 kg/m2, HbA1c>7.5%, treatment with oral 
anti-diabetic drugs for ≥1 year, and/or insulin treatment for ≥3 months. Exclusion criteria included: major 
cardiovascular disease within the past 3 months, carotid artery stenosis >70%, heart failure, recent cancer, renal or 
liver disease, alcohol or drug abuse, unstable retinopathy, pregnancy, breastfeeding, fertile women not using 
anticonception, or allergy towards trial medication. Altogether, 412 type 2 diabetes patients were included in the 
trial and were screened for the presence of GADA with an RSR ELISA kit.  
Number of study subjects: 31 LADA cases 
Acknowledgements: The CIMT trial group is acknowledged for their effort in collecting and characterizing the 
cohort. 
Funding: The CIMT study was funded by an unrestricted grant from Novo Nordisk A/S.  
Cohort reference: Lundby et al. Study rationale and design of the CIMT trial: the Copenhagen Insulin and 
Metformin Therapy trial. Diabetes Obes Metab 2009. 
Conflicts of interest: NA 
 
Cohort name: Inter99 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: Inter99 is a population based intervention cohort, comprising 
individuals from the Copenhagen area. Altogether 6784 individuals participated in the baseline examination. GADA 
were measured in 2531 individuals, with an RSR ELISA kit. 
Number of study subjects: 19 LADA cases 
Acknowledgements: The staff from Research Centre for Prevention and Health, The capital region, Glostrup, 
Denmark is acknowledged their effort in making the Inter99 study possible.  
Funding: The Inter99 study is funded by The Danish Medical Research Council, The Danish Centre for Evaluation 
and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish 
Pharmaceutical Association, Augustinus foundation, Ib Henriksen foundation and Becket foundation. 
Cohort reference: Jørgensen et al. A randomized non-pharmacological intervention study for prevention of 
ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003. 
Conflicts of interest: NA 
 
Cohort name: SDC 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases 
Cohort description/inclusion/exclusion criteria: The SDC cohort comprises patients >18 years with type 2 
diabetes (n=1676) recruited from the outpatient clinic at Steno Diabetes Center, Gentofte, Denmark. Individuals in 
pregnancy, having another cause of diabetes or being of another ethnicity than Danish were excluded. GADA were 
measured in 1595 individuals. Of the 141 LADA patients, GADA were measured with RSR ELISA in 52 patients, 
and with AESKULISA in 89 patients.  
Number of study subjects: 141 LADA cases 
Acknowledgements: NA 
Funding: NA 
Cohort reference: NA 
Conflicts of interest: NA 
 
Copenhagen general acknowledgements: Novo Nordisk Foundation Center for Basic Metabolic Research is an 
independent research center at the University of Copenhagen and is partly funded by an unrestricted donation from 
the Novo Nordisk Foundation. This work was supported by a research grant from the Danish Diabetes Academy 
supported by the Novo Nordisk Foundation, and grants from The Danish Council for Independent Research - 
Medical Sciences. 
 
Cohort name: Diabetes Registry Vasa (DIREVA) 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases/ T1D cases/ T2D cases 
Inclusion/exclusion criteria: LADA 
Age at onset ≥ 35 years 
C-peptide (KLU) > 0.2 nmol/L 
GAD65a (EIA) ≥ 10 U/ml 
 
T1D 
Age at onset < 35 years   
C-peptide (KLU) < 0.2 nmol/L 
 
T2D 
Age at onset ≥ 35 years 
C-peptide (KLU) ≥ 0.2 nmol/L 
GAD65a (EIA) <10 U/ml 
 
Number of study subjects: 3290 
Acknowledgements: Same as for ANDIS 
Funding: DIREVA was supported by the Vasa Hospital district. 
+funding overlapping with ANDIS  
Cohort reference: NA 
Conflicts of interest: None 
Cohort name: GoDARTS 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases):  
• population controls (replication study only) 969 
• LADA cases 206 
• T2D cases 4413 
Inclusion/exclusion criteria: 
• Age diagnosis <35 
• No insulin within 1 year diagnosis 
• GADA positive 
Number of study subjects: (see above) 
Acknowledgements: The Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (GoDARTS) 
cohort collection was funded by The Wellcome Trust and informatics support is provided by the Chief Scientist 
Office, Scotland. E.R.P. holds a Wellcome Trust New Investigator Award (102820/Z/13/Z). 
Funding: NA 
Cohort reference: Diabetes Care. 2014;37(3):718-24. (PMID: 24186880) 
Conflicts of interest: NA 
Cohort name: HUNT 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA and T2D cases and non-diabetic 
population controls 
Inclusion/exclusion criteria: LADA: Self-reported yes to having diabetes, positive for GAD antibodies, initial age 
at diagnosis >30 years old and no insulin treatment within one year of diagnosis. 
T2D: Self-reported yes to having diabetes, GAD antibodies negative, initial age at diagnosis >30 years old and no 
insulin treatment within one year of diagnosis. Age and gender matched to the LADA cases. 
Non-diabetic controls: Self-reported no to ever having diabetes and had non-fasting serum glucose <7.0 mmol/l. 
Age and gender matched to the LADA cases. 
Number of study subjects: 139 LADA, 695 T2D and 695 non-diabetic controls 
Acknowledgements: The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT 
Research Centre (Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and 
Technology), Nord-Trøndelag County Council, Central Norway Regional Health Authority, and the Norwegian 
Institute of Public Health. 
Funding: The K.G. Jebsen Center for Genetic Epidemiology is financed by Stiftelsen Kristian Gerhard Jebsen; 
Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology; the Liaison 
Committee between the Central Norway Regional Health Authority and NTNU; and the Liaison Committee between 
St. Olavs Hospital and the Faculty of Medicine and Health Sciences at NTNU.  
 
The genotyping was financed by the National Institute of Health (NIH), University of Michigan, The Norwegian 
Research Council, the Liaison Committee between the Central Norway Regional Health Authority and NTNU, and 
the Liaison Committee between St. Olavs Hospital and the Faculty of Medicine and Health Sciences at NTNU. 
Cohort references: 
Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, Vatten L, Lund-Larsen PG. The 
Nord-Trøndelag Health Study 1995–97 (HUNT2): objectives. contents. methods and participation. Norsk 
Epidemiologi 2003. 13(1): p. 19-32. 
 
Krokstad S, et al. Cohort Profile: the HUNT Study. Norway. Int J Epidemiol. 2013. 42(4): p. 968-77. 
Nielsen JB et al (2018) Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights 
Biological Pathways and Regulatory Elements Involved in Cardiac Development. Am J Hum Genet. 102(1):103-115 
[29290336].  
 
Conflicts of interest: There are no disclosures to report. 
Cohort name: Malmö Diet and Cancer study 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): Non-diabetic controls 
Inclusion/exclusion criteria: 
Diabetes 
Number of study subjects: 3126 
Acknowledgements: NA 
Funding: NA 
Cohort reference: Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, et al. Long-term 
outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247(1):19-29. 
Epub 2000/02/15. 
Conflicts of interest: None 
Cohort name: Scania Diabetes Registry (SDR) 
Cohort type (population controls/ LADA cases/ T1D cases/ T2D cases): LADA cases/ T1D cases/ T2D cases 
Inclusion/exclusion criteria: 
SDR 
GAD (Wallenberg lab (AU ref < 5.0)  
GAD (Wallenberg lab (IU/ml ref <32)  
C-peptide (Klin kem (RIA) ref 0.25-0.75) 
C-peptide (Klin kem ref 0.3-1.3) 
C-peptide (Lund (ref 0.25-0.75) 
 
LADA 
Age at onset ≥ 35 
GAD ≥ 10 AU 
GAD ≥ 50 IU/ml 
 
T1D 
Age  at onset < 35 
GAD ≥ 20 AU 
GAD ≥ 100 IU/ml 
C-peptide ≥ 0.25 (Klin kem (RIA)) 
C-peptide ≥ 0.3 (Klin kem) 
C-peptide ≥ 0.25 (Lund) 
 
T2D 
BMI > 25 
GAD < 5 AU 
GAD ≤ 34 IU/ml 
C-peptide (Klin kem (RIA)) ≥ 0.75 
C-peptide (Klin kem) ≥ 1.3 
C-peptide (Lund) ≥ 0.75 
For patients that did not fulfill the criteria for any of the above, the diagnosis given by their physician was used 
 
Non-Scandinavian individuals excluded 
Number of study subjects: 3567 
Acknowledgements: NA 
Funding: NA 
Cohort reference: Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD. Classifying diabetes according to the 
new WHO clinical stages. Eur J Epidemiol. 2001;17(11):983-9. Epub 2002/10/17. 
Conflicts of interest:  None 
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